Introducing the Introcan Safety 2 Deep Access IV Catheter
B. Braun Medical Inc. has made a notable advancement in intravenous therapy with the introduction of the Introcan Safety 2 Deep Access IV Catheter. This innovative catheter is designed to improve safety and efficiency in vascular access, ultimately enhancing the quality of patient care.
Key Design Features and Advantages
The Introcan Safety 2 Deep Access IV Catheter incorporates a range of cutting-edge features to tackle common issues in IV therapy. It's specifically built for longer dwell times, which helps decrease the frequency of catheter replacements. A major highlight of this catheter is its fully automatic, passive needlestick protection, which significantly boosts safety for healthcare professionals.
Enhanced Access and Versatility
This catheter's design enables clinicians to tap into deeper veins, making it especially useful for patients with difficult vascular access. This helps ensure that treatments can proceed smoothly, avoiding unnecessary complications. With the Introcan Safety 2, healthcare providers can look forward to a more effective way to administer IV therapy.
Better Patient Outcomes
Research indicates that the Introcan Safety 2 Deep Access IV Catheter can notably extend peripherally inserted venous catheter (PIVC) dwell times—from about 3.8 days with standard long PIVCs to roughly 5.7 days. This improvement reduces the need for unnecessary catheter restarts, which in turn helps protect patients from undergoing more invasive procedures.
Showcasing at the AVA Meeting
B. Braun Medical is thrilled to present the Introcan Safety 2 Deep Access IV Catheter at the upcoming Association for Vascular Access (AVA) Scientific Meeting. The event will be hosted in a dynamic city where attendees can explore the full capabilities of this new product at booth #503. It’s a great chance for professionals to see how the catheter integrates into their existing workflows while enhancing patient safety.
Commitment to Peripheral Advantage
This launch is consistent with B. Braun's Peripheral Advantage Program, which focuses on optimizing clinical skills and enhancing product performance, ultimately leading to better patient experiences. B. Braun is dedicated to supporting healthcare providers in raising care standards for peripheral IV management.
About B. Braun Medical Inc.
B. Braun Medical Inc. is a leader in innovation within smart infusion therapy. The company is devoted to developing safe and effective products that protect healthcare professionals while enhancing patient outcomes. With its headquarters in a well-known city, B. Braun boasts a strong presence throughout North America and a global workforce committed to providing expertise in healthcare solutions.
Globally, B. Braun employs over 64,000 people across many countries, promoting a philosophy of Sharing Expertise. This focus on collaboration allows the company to address significant challenges in healthcare today.
Frequently Asked Questions
What is the significance of the Introcan Safety 2 Deep Access IV Catheter?
This catheter enhances safety for healthcare providers through passive needlestick protection and facilitates access to deeper veins, leading to improved patient care and outcomes.
How long can the Deep Access IV Catheter stay in a patient?
Studies show that this catheter can remain in place for about 5.7 days, which is a significant improvement compared to standard catheters.
Where can healthcare professionals see the catheter in use?
B. Braun will showcase the Introcan Safety 2 Deep Access IV Catheter at the AVA Scientific Meeting.
What is B. Braun's core philosophy?
B. Braun adheres to a Sharing Expertise philosophy that encourages collaboration and the sharing of knowledge within the healthcare field.
How does this catheter fit within B. Braun's Peripheral Advantage Program?
The catheter's launch supports efforts to enhance clinical skills, improve product performance, and ultimately enrich the patient care experience in peripheral intravenous therapy.
